查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1954069

日本非處方藥市場規模、佔有率、趨勢及預測（依產品類型、給藥途徑、劑型、通路及地區分類，2026-2034年）

Japan Over The Counter (OTC) Drugs Market Size, Share, Trends and Forecast by Product Type, Route of Administration, Dosage Form, Distribution Channel, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

2025年，日本非處方藥市場規模達110.84億美元。 IMARC Group預測，到2034年，該市場規模將達到172.325億美元，2026年至2034年的複合年成長率為5.03%。推動市場成長的因素包括人口快速老化、健康意識增強、文明病增加、產品配方創新、政府有利的監管政策、預防性醫療保健的廣泛應用、電子商務的普及以及消費者對天然和有機藥物的需求成長。

日本非處方藥市場趨勢：

人口老化加劇

人口老化正顯著影響非處方藥市場，並推動人們對自我護理解決方案的需求。這是加速日本非處方藥市場成長的關鍵因素之一。截至2024年9月，日本65歲以上人口將達到創紀錄的3,625萬，佔總人口的29.3%。這老年人人口往往面臨高血壓、關節炎和糖尿病等慢性疾病的困擾。隨著醫療成本的持續上漲和住院治療選擇的減少，越來越多的老年人開始依賴成藥來自主管理常見症狀。非處方藥的便利性和經濟性促使老年人轉向自我保健，使患者能夠避免頻繁前往醫療機構。日本完善的醫療保健基礎設施進一步強化了這一趨勢，確保了非處方藥在藥局和藥局的廣泛供應。

提高健康意識

消費者健康意識的提升是推動日本非處方藥（OTC）市場佔有率成長的主要因素之一。越來越多的人在尋求醫療干預之前，選擇自行處理輕微的健康問題，這促進了市場成長。此外，人們對自我護理保健益處的認知不斷提高，包括使用成藥治療感冒、消化器官系統問題和輕微疼痛等常見疾病，進一步加速了這一趨勢。日本人越來越意識到文明病的風險，並積極尋求預防措施。媒體健康內容的增加、數位管道資訊的普及以及政府的健康宣傳活動也推動了消費者在成藥上的支出。這些預防措施帶動了對多種非處方藥產品的需求成長，包括維生素、免疫力增強劑和護膚品，推動了市場擴張。

拓展零售通路

零售通路的擴張是推動市場成長的關鍵因素。例如，2025年1月，日本零售額年增3.9%，連續第34個月實現成長。成藥透過如此廣泛的零售通路網路銷售，讓消費者無需就醫即可輕鬆獲得所需藥品。藥局是最受歡迎的管道之一，提供各式各樣的產品，滿足消費者從止痛藥到個人保養用品等各種需求。此外，網路零售的興起帶來了更豐富的產品選擇、更便捷的價格比較以及宅配服務，進一步提振了日本非處方藥市場的前景。同時，分銷管道的擴張有助於市場滲透到不同人群，並促進市場競爭。這反過來又鼓勵產品創新和改進，從而進一步刺激市場成長。

本報告解答的關鍵問題

  • 日本非處方藥市場目前發展狀況如何？您認為未來幾年它將如何發展？
  • 日本非處方成藥）市場按產品類型分類的組成是什麼？
  • 日本非處方成藥）市場是如何依給藥途徑細分的？
  • 日本非處方成藥市場按劑型是如何分類的？
  • 日本非處方成藥）市場按通路分類的組成是怎樣的？
  • 日本非處方成藥市場按地區分類的情況如何？
  • 請介紹日本非處方藥市場價值鏈的各個環節。
  • 日本非處方成藥市場的主要促進因素和挑戰是什麼？
  • 日本非處方藥市場的結構是怎麼樣的？主要參與者有哪些？
  • 日本非處方藥市場競爭有多激烈？

目錄

第1章：序言

第2章：調查範圍與調查方法

  • 調查目標
  • 相關利益者
  • 數據來源
  • 市場估值
  • 調查方法

第3章執行摘要

第4章：日本非處方藥市場：引言

  • 概述
  • 市場動態
  • 產業趨勢
  • 競爭資訊

第5章：日本非處方藥市場概況

  • 過去和當前的市場趨勢（2020-2025）
  • 市場預測（2026-2034）

第6章：日本非處方藥市場：依產品類型分類

  • 咳嗽、感冒和流感產品
  • 止痛藥
  • 皮膚科產品
  • 胃腸病學
  • 維生素、礦物質和補充劑 (VMS)
  • 減重和飲食產品
  • 眼科產品
  • 助眠劑
  • 其他

第7章：日本非處方藥市場－依給藥途徑細分

  • 口服
  • 注射
  • 外用
  • 其他

第8章：日本非處方藥市場－依劑型細分

  • 片劑和膠囊
  • 液體
  • 軟膏
  • 其他

第9章 日本非處方藥市場－依銷售管道細分

  • 醫院藥房
  • 零售藥房
  • 網路藥房
  • 其他

第10章：日本非處方藥市場：依地區分類

  • 關東地區
  • 關西、近畿地區
  • 中部地區
  • 九州和沖繩地區
  • 東北部地區
  • 中國地區
  • 北海道地區
  • 四國地區

第11章：日本非處方藥市場：競爭格局

  • 概述
  • 市場結構
  • 市場公司定位
  • 關鍵成功策略
  • 競爭對手儀錶板
  • 企業估值象限

第12章主要企業概況

第13章：日本非處方藥市場：產業分析

  • 促進因素、限制因素和機遇
  • 波特五力分析
  • 價值鏈分析

第14章附錄

簡介目錄
Product Code: SR112026A33582

The Japan over the counter (OTC) drugs market size reached USD 11,084.0 Million in 2025 . Looking forward, IMARC Group expects the market to reach USD 17,232.5 Million by 2034 , exhibiting a growth rate (CAGR) of 5.03% during 2026-2034 . Burgeoning aging population, surging health awareness, rising lifestyle diseases, innovation in product formulations, favorable government regulations, the popularity of preventive healthcare, growing e-commerce adoption, and a shift toward natural, organic drug alternatives are factors propelling the market growth.

JAPAN OVER THE COUNTER (OTC) DRUGS MARKET TRENDS:

Growing Geriatric Population

The aging population significantly influences the OTC drug market, driving the demand for self-care solutions, which is one of the key factors accelerating the Japan over the counter (OTC) drugs market growth. As of September 2024, Japan's elderly population reached a record high of 36.25 million individuals aged 65 or older, accounting for 29.3% of the total population. The elderly demographic, which constitutes a considerable portion of the population, often faces chronic health issues such as hypertension, arthritis, and diabetes. As healthcare costs continue to rise and the availability of in-patient treatments becomes more limited, many seniors are turning to OTC drugs for managing common ailments independently. The shift towards self-medication among older adults is encouraged by the convenience and affordability of OTC products, which allow them to avoid frequent visits to healthcare providers. This trend is further compounded by Japan's well-established healthcare infrastructure, which supports widespread access to OTC drugs in drugstores and pharmacies.

Increased Health Awareness

Increasing health consciousness among consumers is one of the primary factors fostering the growth of the Japan over the counter (OTC) drugs market share. An increasing number of people are opting for preventative healthcare and seeking to mitigate minor health issues themselves before resorting to medical intervention, which is boosting the market growth. This is further fueled by the escalating awareness of the advantages of staying well via self-care, which encompasses the use of OTC medicines to treat common ailments like colds, digestive problems and minor aches. The Japanese are becoming increasingly cognizant of the likelihood of lifestyle diseases and searching for ways to prevent them. Consumers' willingness to spend on OTC medications has also been driven by the increased amount of health-related content in the media, the availability of information via digital channels, as well as government health campaigns. This trend of preventative measures has led to a higher demand for several OTC products like vitamins, immunity boosters and skincare treatments which are also driving the market expansion.

Retail Channel Expansion

The expansion of retail channels is a crucial factor driving the market growth. For instance, retail sales in Japan advanced by 3.9% year-on-year in January 2025, marking the 34th consecutive month of growth. The availability of OTC drugs through such a broad network of retail channels has made it easier for consumers to access the products they need without visiting a doctor. Drugstores are among the most popular channels, offering a variety of products that cater to diverse consumer needs, from pain relievers to personal care items. Additionally, the rise of online retail has allowed for greater product selection, better price comparison, and doorstep delivery, further creating a positive Japan over the counter (OTC) drugs market outlook. Moreover, the expansion of distribution channels supports market penetration across different demographics and encourages competition, which drives innovation and improvement in product offerings, which is further stimulating the market growth.

JAPAN OVER THE COUNTER (OTC) DRUGS MARKET SEGMENTATION:

Product Type Insights:

  • Cough, Cold and Flu Products
  • Analgesics
  • Dermatology Products
  • Gastrointestinal Products
  • Vitamins, Minerals and Supplements (VMS)
  • Weight-loss/Dietary Products
  • Ophthalmic Products
  • Sleeping Aids
  • Others

Route Of Administration Insights:

  • Oral
  • Parenteral
  • Topical

Dosage Form Insights:

  • Tablets and Capsules
  • Liquids
  • Ointments

Distribution Channel Insights:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central/Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

  • KEY QUESTIONS ANSWERED IN THIS REPORT
  • How has the Japan over the counter (OTC) drugs market performed so far and how will it perform in the coming years?
  • What is the breakup of the Japan over the counter (OTC) drugs market on the basis of product type?
  • What is the breakup of the Japan over the counter (OTC) drugs market on the basis of route of administration?
  • What is the breakup of the Japan over the counter (OTC) drugs market on the basis of dosage form?
  • What is the breakup of the Japan over the counter (OTC) drugs market on the basis of distribution channel?
  • What is the breakup of the Japan over the counter (OTC) drugs market on the basis of region?
  • What are the various stages in the value chain of the Japan over the counter (OTC) drugs market?
  • What are the key driving factors and challenges in the Japan over the counter (OTC) drugs market?
  • What is the structure of the Japan over the counter (OTC) drugs market and who are the key players?
  • What is the degree of competition in the Japan over the counter (OTC) drugs market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Over The Counter (OTC) Drugs Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Over The Counter (OTC) Drugs Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Over The Counter (OTC) Drugs Market - Breakup by Product Type

  • 6.1 Cough, Cold and Flu Products
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Analgesics
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Dermatology Products
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 Gastrointestinal Products
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 Vitamins, Minerals and Supplements (VMS)
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2020-2025)
    • 6.5.3 Market Forecast (2026-2034)
  • 6.6 Weight-loss/Dietary Products
    • 6.6.1 Overview
    • 6.6.2 Historical and Current Market Trends (2020-2025)
    • 6.6.3 Market Forecast (2026-2034)
  • 6.7 Ophthalmic Products
    • 6.7.1 Overview
    • 6.7.2 Historical and Current Market Trends (2020-2025)
    • 6.7.3 Market Forecast (2026-2034)
  • 6.8 Sleeping Aids
    • 6.8.1 Overview
    • 6.8.2 Historical and Current Market Trends (2020-2025)
    • 6.8.3 Market Forecast (2026-2034)
  • 6.9 Others
    • 6.9.1 Historical and Current Market Trends (2020-2025)
    • 6.9.2 Market Forecast (2026-2034)

7 Japan Over The Counter (OTC) Drugs Market - Breakup by Route of Administration

  • 7.1 Oral
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Parenteral
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Topical
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Others
    • 7.4.1 Historical and Current Market Trends (2020-2025)
    • 7.4.2 Market Forecast (2026-2034)

8 Japan Over The Counter (OTC) Drugs Market - Breakup by Dosage Form

  • 8.1 Tablets and Capsules
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Liquids
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Ointments
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)
  • 8.4 Others
    • 8.4.1 Historical and Current Market Trends (2020-2025)
    • 8.4.2 Market Forecast (2026-2034)

9 Japan Over The Counter (OTC) Drugs Market - Breakup by Distribution Channel

  • 9.1 Hospital Pharmacies
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Forecast (2026-2034)
  • 9.2 Retail Pharmacies
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Forecast (2026-2034)
  • 9.3 Online Pharmacies
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Forecast (2026-2034)
  • 9.4 Others
    • 9.4.1 Historical and Current Market Trends (2020-2025)
    • 9.4.2 Market Forecast (2026-2034)

10 Japan Over The Counter (OTC) Drugs Market - Breakup by Region

  • 10.1 Kanto Region
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2020-2025)
    • 10.1.3 Market Breakup by Product Type
    • 10.1.4 Market Breakup by Route of Administration
    • 10.1.5 Market Breakup by Dosage Form
    • 10.1.6 Market Breakup by Distribution Channel
    • 10.1.7 Key Players
    • 10.1.8 Market Forecast (2026-2034)
  • 10.2 Kansai/Kinki Region
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2020-2025)
    • 10.2.3 Market Breakup by Product Type
    • 10.2.4 Market Breakup by Route of Administration
    • 10.2.5 Market Breakup by Dosage Form
    • 10.2.6 Market Breakup by Distribution Channel
    • 10.2.7 Key Players
    • 10.2.8 Market Forecast (2026-2034)
  • 10.3 Central/ Chubu Region
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2020-2025)
    • 10.3.3 Market Breakup by Product Type
    • 10.3.4 Market Breakup by Route of Administration
    • 10.3.5 Market Breakup by Dosage Form
    • 10.3.6 Market Breakup by Distribution Channel
    • 10.3.7 Key Players
    • 10.3.8 Market Forecast (2026-2034)
  • 10.4 Kyushu-Okinawa Region
    • 10.4.1 Overview
    • 10.4.2 Historical and Current Market Trends (2020-2025)
    • 10.4.3 Market Breakup by Product Type
    • 10.4.4 Market Breakup by Route of Administration
    • 10.4.5 Market Breakup by Dosage Form
    • 10.4.6 Market Breakup by Distribution Channel
    • 10.4.7 Key Players
    • 10.4.8 Market Forecast (2026-2034)
  • 10.5 Tohoku Region
    • 10.5.1 Overview
    • 10.5.2 Historical and Current Market Trends (2020-2025)
    • 10.5.3 Market Breakup by Product Type
    • 10.5.4 Market Breakup by Route of Administration
    • 10.5.5 Market Breakup by Dosage Form
    • 10.5.6 Market Breakup by Distribution Channel
    • 10.5.7 Key Players
    • 10.5.8 Market Forecast (2026-2034)
  • 10.6 Chugoku Region
    • 10.6.1 Overview
    • 10.6.2 Historical and Current Market Trends (2020-2025)
    • 10.6.3 Market Breakup by Product Type
    • 10.6.4 Market Breakup by Route of Administration
    • 10.6.5 Market Breakup by Dosage Form
    • 10.6.6 Market Breakup by Distribution Channel
    • 10.6.7 Key Players
    • 10.6.8 Market Forecast (2026-2034)
  • 10.7 Hokkaido Region
    • 10.7.1 Overview
    • 10.7.2 Historical and Current Market Trends (2020-2025)
    • 10.7.3 Market Breakup by Product Type
    • 10.7.4 Market Breakup by Route of Administration
    • 10.7.5 Market Breakup by Dosage Form
    • 10.7.6 Market Breakup by Distribution Channel
    • 10.7.7 Key Players
    • 10.7.8 Market Forecast (2026-2034)
  • 10.8 Shikoku Region
    • 10.8.1 Overview
    • 10.8.2 Historical and Current Market Trends (2020-2025)
    • 10.8.3 Market Breakup by Product Type
    • 10.8.4 Market Breakup by Route of Administration
    • 10.8.5 Market Breakup by Dosage Form
    • 10.8.6 Market Breakup by Distribution Channel
    • 10.8.7 Key Players
    • 10.8.8 Market Forecast (2026-2034)

11 Japan Over The Counter (OTC) Drugs Market - Competitive Landscape

  • 11.1 Overview
  • 11.2 Market Structure
  • 11.3 Market Player Positioning
  • 11.4 Top Winning Strategies
  • 11.5 Competitive Dashboard
  • 11.6 Company Evaluation Quadrant

12 Profiles of Key Players

  • 12.1 Company A
    • 12.1.1 Business Overview
    • 12.1.2 Products Offered
    • 12.1.3 Business Strategies
    • 12.1.4 SWOT Analysis
    • 12.1.5 Major News and Events
  • 12.2 Company B
    • 12.2.1 Business Overview
    • 12.2.2 Products Offered
    • 12.2.3 Business Strategies
    • 12.2.4 SWOT Analysis
    • 12.2.5 Major News and Events
  • 12.3 Company C
    • 12.3.1 Business Overview
    • 12.3.2 Products Offered
    • 12.3.3 Business Strategies
    • 12.3.4 SWOT Analysis
    • 12.3.5 Major News and Events
  • 12.4 Company D
    • 12.4.1 Business Overview
    • 12.4.2 Products Offered
    • 12.4.3 Business Strategies
    • 12.4.4 SWOT Analysis
    • 12.4.5 Major News and Events
  • 12.5 Company E
    • 12.5.1 Business Overview
    • 12.5.2 Products Offered
    • 12.5.3 Business Strategies
    • 12.5.4 SWOT Analysis
    • 12.5.5 Major News and Events

13 Japan Over The Counter (OTC) Drugs Market - Industry Analysis

  • 13.1 Drivers, Restraints, and Opportunities
    • 13.1.1 Overview
    • 13.1.2 Drivers
    • 13.1.3 Restraints
    • 13.1.4 Opportunities
  • 13.2 Porters Five Forces Analysis
    • 13.2.1 Overview
    • 13.2.2 Bargaining Power of Buyers
    • 13.2.3 Bargaining Power of Suppliers
    • 13.2.4 Degree of Competition
    • 13.2.5 Threat of New Entrants
    • 13.2.6 Threat of Substitutes
  • 13.3 Value Chain Analysis

14 Appendix